Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Correction Of Presbyopia With Pseudophakic Monovision

T.R. Wallin; S.I. Mian; D.C. Musch; P.R. Lichter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):646.

ARVO Annual Meeting Abstract May 2006

Depression, Mood Indicators, and Self–Reported Visual Function at Baseline in the Collaborative Initial Glaucoma Treatment Study

H.D. Jampel; K.D. Frick; N.K. Janz; P.A. Wren; D.C. Musch; P.R. Lichter; CIGTS Investigators

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3382.

ARVO Annual Meeting Abstract May 2006

Baseline Factors Associated With Visual Field Progression During Long–Term Treatment for Newly Diagnosed Open–Angle Glaucoma

D.C. Musch; B.W. Gillespie; L.M. Niziol; P.R. Lichter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3450.

ARVO Annual Meeting Abstract May 2006

Baseline Factors Associated With IOP Mean and Variability During Long–Term Treatment for Newly–Diagnosed Open–Angle Glaucoma

L.M. Niziol; D.C. Musch; B.W. Gillespie; P.R. Lichter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3451.

ARVO Annual Meeting Abstract May 2005

Converting to the SITA–Standard Visual Field Test Strategy in the Follow–up Phase of a Clinical Trial: Agreement With the Full Threshold Visual Field Test Strategy

D.C. Musch; B.W. Gillespie; B.M. Motyka; R.P. Mills; P.R. Lichter; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3730.

ARVO Annual Meeting Abstract May 2004

Optineurin (OPTN) Plays a Minor Role in Primary Open–Angle Glaucoma (POAG)

H.S. Pawar; R.M. Ayala–Lugo; P.R. Lichter; J.A. Eadie; S.E. Moroi; C.A. Downs; V. Azocar; W.C. Bromley; E. Oben–Nyarkoh; J.E. Richards

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4403.

ARVO Annual Meeting Abstract May 2004

Subsurface Photodisruption for Potential Noninvasive Glaucoma Surgery

H.–L. Liu; M. Eibschitz–Tsimhoni; G.J. R. Spooner; P.R. Lichter; M. Mourou; G. Mourou; T. Juhasz

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1002.

ARVO Annual Meeting Abstract May 2004

Does Initial Treatment Approach Matter for Newly–Diagnosed Open–Angle Glaucoma? The Differential Role of Baseline Visual Field Severity in Subsequent Loss.

D.C. Musch; B.W. Gillespie; P.R. Lichter; R. Varma; G.L. Skuta; K.E. Guire; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):969.

ARVO Annual Meeting Abstract May 2003

Prognostic Factors for Failure of Initial Treatment of POAG

D.C. Musch; P.R. Lichter; R.P. Mills; K.E. Guire; B.W. Gillespie; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):92.

ARVO Annual Meeting Abstract May 2003

What is the IOP-reducing Effect of Argon Laser Trabeculoplasy After Failure of Initial Treatment with Medications Versus Surgery?

G.L. Skuta; L.F. Cashwell; P.R. Lichter; D.C. Musch; K.E. Guire; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1216.

Advertisement